New methods for testing multiple treatments at once
Novel designs for multi-arm multi-dose multi-stage platform trials
['FUNDING_R21'] · UNIVERSITY OF TX MD ANDERSON CAN CTR · NIH-11032291
This study is looking at new ways to test multiple treatments at the same time to help speed up the process of finding effective drugs for complex diseases like Alzheimer's and cancer, so patients can get access to better options more quickly.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TX MD ANDERSON CAN CTR (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-11032291 on ClinicalTrials.gov |
What this research studies
This research focuses on improving the drug development process by using innovative trial designs that allow for the simultaneous evaluation of multiple treatments. By employing a multi-arm multi-stage platform trial approach, the research aims to enhance the efficiency of clinical trials, particularly for complex diseases like Alzheimer's and cancer. Patients may benefit from faster access to effective treatments as the trials can adapt based on real-time results, potentially reducing the time and resources needed for drug approval.
Who could benefit from this research
Good fit: Ideal candidates for participation would include individuals diagnosed with Alzheimer's disease or other complex conditions being targeted by the trial.
Not a fit: Patients with conditions not addressed by the trial or those who do not meet the specific eligibility criteria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to quicker and more effective treatment options for patients with complex diseases.
How similar studies have performed: Previous research has shown that multi-arm trials can improve the efficiency of drug development, suggesting a promising avenue for this novel approach.
Where this research is happening
HOUSTON, UNITED STATES
- UNIVERSITY OF TX MD ANDERSON CAN CTR — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LIN, RUITAO — UNIVERSITY OF TX MD ANDERSON CAN CTR
- Study coordinator: LIN, RUITAO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease